Ceftriaxone for Post-Treatment Lyme Disease
NCT06785402
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Enrollment challenges
Conditions
Post-Treatment Lyme Disease Syndrome
Interventions
DRUG:
Ceftriaxone treatment
DRUG:
Placebo
Sponsor
Hackensack Meridian Health
Collaborators
[object Object]